Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

December 27, 2019 00:23:35
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?
Critical Care Perspectives in Emergency Medicine
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

Dec 27 2019 | 00:23:35

/

Show Notes

Up to one-third of patients with status epilepticus will not respond to benzodiazepines.  Unfortunately, treatment of benzodiazepine-refractory status epilepticus is not well studied.  The longer seizures persist, the worse patients do.  In this podcast, we discuss the results of the recently completed ESETT trial that evaluated three anticonvulsant medications for status epilepticus.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode

February 05, 2019 00:30:53
Episode Cover

ED Sepsis Screening - Is qSOFA Really Better?

As EDs across the country strive to meet sepsis benchmark metrics, many have implemented a variety of screening tools. With the publication of Sepsis-3,...

Listen

Episode

September 25, 2018 00:24:02
Episode Cover

PARAMEDIC2 - Is Epi Useful in OHCA?

Recent trials have produced conflicting results on the benefit of epinephrine in patients with OHCA.  PARAMEDIC2 was just published and is the largest randomized...

Listen

Episode

April 15, 2018 00:28:52
Episode Cover

Acute Aortic Syndromes

Acute aortic syndromes such as aortic dissection are incredibly stressful and challenging to manage.  In this episode, we tackle the difficult management pearls and...

Listen